Washington Trust Advisors’s GSK GSK Stock Holding History

Washington Trust Advisors’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$76.3K	Hold	1,456	–	–	0.01%	323
2026 Q1	$80.4K	Hold	1,456	–	–	0.01%	313
2025 Q4	$71.4K	Hold	1,456	–	–	0.01%	326
2025 Q3	$62.8K	Hold	1,456	–	–	﹤0.01%	336
2025 Q2	$55.9K	Hold	1,456	–	–	﹤0.01%	314
2025 Q1	$56.4K	Hold	1,456	–	–	0.01%	314
2024 Q4	$49.2K	Hold	1,456	–	–	﹤0.01%	325
2024 Q3	$59.5K	Hold	1,456	–	–	0.01%	304
2024 Q2	$56.1K	Hold	1,456	–	–	0.01%	303
2024 Q1	$62.4K	Hold	1,456	–	–	0.01%	289
2023 Q4	$54K	Hold	1,456	–	–	0.01%	300
2023 Q3	$52.8K	Buy	+1,456	New	+$51.7K	0.01%	295

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Washington Trust Advisors's GSK Position: Q2 2026 in Review

Washington Trust Advisors held its GSK (GSK) position steady in Q2 2026 at 1,456 shares worth $76.3K. The position accounts for 0.01% of the portfolio, ranked #323.

Washington Trust Advisors first reported a position in GSK in Q3 2023 and has held it in 12 quarters since. The position peaked at $80.4K in Q1 2026. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Washington Trust Advisors held 1,456 shares of GSK worth $76.3K as of Q2 2026.
Washington Trust Advisors left its GSK share count unchanged in Q2 2026.
GSK made up 0.01% of Washington Trust Advisors's portfolio in Q2 2026, its #323 holding.
Washington Trust Advisors first reported a position in GSK in Q3 2023 and has held it in 12 quarters since.
Washington Trust Advisors's GSK position peaked at $80.4K in Q1 2026.
1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Washington Trust Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.